Why Indian pharma isn't scared of a 100% tariff (yet)
Last Tuesday, Trump announced 100% tariffs on generic medicines imported into the US. By Wednesday, Indian pharma stocks were already falling even though the tariff doesn't take effect for two years. Trump wants import companies to reshore their manufacturing to the US so that the country can secure life-saving…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Daybreak
See all episodes →
UPI is the trojan horse taking small banks into HDFC, Axis's credit-card empire
How India's rich are finding returns in the country's court backlog
Amazon’s quick-commerce win will be less about speed and more about Prime
Similar episodes from other shows
More like Daybreak →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.